|
66 Companies |
|
64 Products |
|
64 Products |
|
38 Mechanisms of Action |
|
0 Trials |
|
1523 News |
|
| «12...1718192021222324252627...3031» |
- ||| Fluzone (influenza vaccine) / Sanofi
Trial completion: Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer (clinicaltrials.gov) - Mar 25, 2013
P1, N=125, Completed, Sponsor: NanoBio Corporation
Active, not recruiting --> Completed
- New P1 trial: A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1 (clinicaltrials.gov) - Mar 24, 2013
P1, N=48, Recruiting, Sponsor: University of Oxford
- | Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
New P4 trial: Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women (clinicaltrials.gov) - Mar 20, 2013
P4, N=150, Active, not recruiting, Sponsor: University of Witwatersrand, South Africa
- |||| Fluzone (influenza vaccine) / Sanofi, Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
Trial completion: Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults (clinicaltrials.gov) - Mar 17, 2013
P4, N=300, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
New P4 trial: Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women (clinicaltrials.gov) - Mar 14, 2013
P4, N=105, Completed, Sponsor: University of Witwatersrand, South Africa
- Trial withdrawal: A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults (clinicaltrials.gov) - Mar 13, 2013
P1, N=0, Withdrawn, Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Active, not recruiting --> Completed Recruiting --> Withdrawn
- Enrollment change: A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults (clinicaltrials.gov) - Mar 13, 2013
P1, N=0, Withdrawn, Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Recruiting --> Withdrawn N=240 --> 0
- | Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
New P4 trial: Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults (clinicaltrials.gov) - Mar 13, 2013
P4, N=360, Not yet recruiting, Sponsor: University of Witwatersrand, South Africa
- |||| Trial completion: Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants (clinicaltrials.gov) - Mar 12, 2013
P4, N=310, Completed, Sponsor: Sinovac Biotech Co., Ltd
N=240 --> 0 Enrolling by invitation --> Completed
- |||| Trial completion: A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines (clinicaltrials.gov) - Mar 12, 2013
P4, N=100, Completed, Sponsor: Sinovac Biotech Co., Ltd
Enrolling by invitation --> Completed Enrolling by invitation --> Completed
- Enrollment closed: A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1 (clinicaltrials.gov) - Mar 12, 2013
P1, N=18, Active, not recruiting, Sponsor: University of Oxford
Enrolling by invitation --> Completed Recruiting --> Active, not recruiting
- Fluarix (influenza virus trivalent vaccine) / GSK
New P2/3 trial: Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya (clinicaltrials.gov) - Mar 11, 2013
P2/3, N=0, Withdrawn, Sponsor: Centers for Disease Control and Prevention
- Enrollment change: A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom (clinicaltrials.gov) - Mar 6, 2013
P=N/A, N=19, Terminated, Sponsor: GlaxoSmithKline
Recruiting --> Active, not recruiting N=220 --> 19
- ||||||| Priorix (GSK209762) / GSK
Trial completion, Head-to-Head: Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years. (clinicaltrials.gov) - Mar 6, 2013
P3, N=433, Completed, Sponsor: GlaxoSmithKline
N=220 --> 19 Active, not recruiting --> Completed
- |||| Afluria (influenza vaccine) / CSL Behring
Trial completion, Head-to-Head: JIFI: Jet Injection for Influenza (clinicaltrials.gov) - Mar 4, 2013
P4, N=1252, Completed, Sponsor: PharmaJet, Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- ||||| oseltamivir / Generic mfg.
New P4 trial: Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza (clinicaltrials.gov) - Mar 3, 2013
P4, N=370, Recruiting, Sponsor: Materia Medica Holding
- ||||| Naphcon-A (naphazoline HCl) / Novartis, Alervil (pheniramine maleate) / Incepta
Trial initiation date: Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal (clinicaltrials.gov) - Feb 28, 2013
P3, N=212, Active, not recruiting, Sponsor: EMS
Recruiting --> Completed Initiation date: Aug 2012 --> Jun 2013
- ||||| Trial initiation date, Monotherapy, Head-to-Head: Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment (clinicaltrials.gov) - Feb 25, 2013
P3, N=120, Recruiting, Sponsor: EMS
Initiation date: Aug 2012 --> Jun 2013 Initiation date: Mar 2011 --> Feb 2013
- |||||| Enrollment open, Monotherapy, Head-to-Head: Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment (clinicaltrials.gov) - Feb 25, 2013
P3, N=120, Recruiting, Sponsor: EMS
Initiation date: Mar 2011 --> Feb 2013 Not yet recruiting --> Recruiting
- ||||| oseltamivir / Generic mfg.
Enrollment change: A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza (clinicaltrials.gov) - Feb 24, 2013
P3, N=118, Completed, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Recruiting N=200 --> 118
- FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo, Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Enrollment open: Live Versus Inactivated Influenza Vaccine Study in Hutterite Children (clinicaltrials.gov) - Feb 24, 2013
P4, N=3800, Recruiting, Sponsor: McMaster University
N=200 --> 118 Not yet recruiting --> Recruiting
- rosuvastatin / Generic mfg.
New P2 trial: CHAT Pilot: Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial (clinicaltrials.gov) - Feb 24, 2013
P2, N=8, Terminated, Sponsor: Canadian Critical Care Trials Group
- Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Enrollment change: Direct and Indirect Protection by Influenza Vaccine Given to Children in India (clinicaltrials.gov) - Feb 20, 2013
P4, N=4598, Completed, Sponsor: Wayne Sullender, M.D.
Not yet recruiting --> Recruiting N=3500 --> 4598
- || New P3 trial: A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh (clinicaltrials.gov) - Feb 20, 2013
P3, N=1761, Active, not recruiting, Sponsor: Program for Appropriate Technology in Health
- Trial completion: Influenza Burden Assessment in the United States, July1997 - up to April 2009 (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=1, Completed, Sponsor: GlaxoSmithKline
N=3500 --> 4598 Not yet recruiting --> Completed
- Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial completion: Direct and Indirect Protection by Influenza Vaccine Given to Children in India (clinicaltrials.gov) - Feb 20, 2013
P4, N=4598, Completed, Sponsor: Wayne Sullender, M.D.
Not yet recruiting --> Completed Recruiting --> Completed
- |||| Fluzone (influenza vaccine) / Sanofi
Trial completion: LIfT: A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 (clinicaltrials.gov) - Feb 20, 2013
P1/2, N=152, Completed, Sponsor: Liquidia Technologies, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- rosuvastatin / Generic mfg.
Trial termination: CHAT: Collaborative H1N1 Adjuvant Treatment Pilot Trial (clinicaltrials.gov) - Feb 19, 2013
P2, N=8, Terminated, Sponsor: Canadian Critical Care Trials Group
Active, not recruiting --> Completed Active, not recruiting --> Terminated; H1N1 pandemic concluded in early 2010
- rosuvastatin / Generic mfg.
Enrollment change: CHAT: Collaborative H1N1 Adjuvant Treatment Pilot Trial (clinicaltrials.gov) - Feb 19, 2013
P2, N=8, Terminated, Sponsor: Canadian Critical Care Trials Group
Active, not recruiting --> Terminated; H1N1 pandemic concluded in early 2010 N=80 --> 8
- || New P2/3 trial: Vitamin B12 Supplementation During Pregnancy (clinicaltrials.gov) - Feb 18, 2013
P2/3, N=120, Completed, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
- |||| Trial completion: A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season (clinicaltrials.gov) - Feb 18, 2013
P4, N=52, Completed, Sponsor: Crucell Holland BV
N=80 --> 8 Active, not recruiting --> Completed
- || Trial initiation date: Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus (clinicaltrials.gov) - Feb 17, 2013
P1, N=64, Completed, Sponsor: Crucell Holland BV
Active, not recruiting --> Completed Initiation date: Aug 2011 --> Feb 2013
- ||||| Inavir (laninamivir) / Daiichi Sankyo
New P2 trial: Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza (clinicaltrials.gov) - Feb 14, 2013
P2, N=636, Recruiting, Sponsor: Biota Scientific Management Pty Ltd
- |||| Trial completion: A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults (clinicaltrials.gov) - Feb 14, 2013
P2, N=500, Completed, Sponsor: Novavax
Initiation date: Aug 2011 --> Feb 2013 Active, not recruiting --> Completed
- Trial completion: Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7 (clinicaltrials.gov) - Feb 11, 2013
P1, N=25, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Recruiting --> Completed
- oseltamivir / Generic mfg.
Enrollment open: A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection (clinicaltrials.gov) - Feb 10, 2013
P1, N=20, Recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 Influenza (clinicaltrials.gov) - Feb 7, 2013
P1, N=20, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- favipiravir / Generic mfg.
Trial completion: T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza (clinicaltrials.gov) - Feb 6, 2013
P1/2, N=550, Completed, Sponsor: FujiFilm Pharmaceuticals U.S.A., Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- | Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial initiation date: Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women (clinicaltrials.gov) - Feb 5, 2013
P3, N=789, Active, not recruiting, Sponsor: University of Witwatersrand, South Africa
Recruiting --> Completed Initiation date: Jun 2012 --> Sep 2012
- | Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Enrollment closed: MatfluHIVneg: Influenza Vaccine Trial in HIV Uninfected Pregnant Women (clinicaltrials.gov) - Feb 5, 2013
P3, N=2100, Active, not recruiting, Sponsor: University of Witwatersrand, South Africa
Initiation date: Jun 2012 --> Sep 2012 Recruiting --> Active, not recruiting
- | Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial completion: MatfluHIVpos: Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity (clinicaltrials.gov) - Feb 5, 2013
P2/3, N=194, Completed, Sponsor: University of Witwatersrand, South Africa
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion: Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine (clinicaltrials.gov) - Feb 4, 2013
P2, N=309, Completed, Sponsor: PATH Vaccine Solutions
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants (clinicaltrials.gov) - Feb 4, 2013
P=N/A, N=1152, Completed, Sponsor: Butantan Institute
Active, not recruiting --> Completed N=2150 --> 1152
- Enrollment change: Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients (clinicaltrials.gov) - Feb 3, 2013
P1, N=44, Completed, Sponsor: Vanderbilt-Ingram Cancer Center
N=2150 --> 1152 N=60 --> 44
- Trial completion: Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients (clinicaltrials.gov) - Feb 3, 2013
P1, N=44, Completed, Sponsor: Vanderbilt-Ingram Cancer Center
N=60 --> 44 Active, not recruiting --> Completed
- | Enrollment change: Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu) (clinicaltrials.gov) - Jan 30, 2013
P2/3, N=240, Completed, Sponsor: Barts & The London NHS Trust
Active, not recruiting --> Completed N=720 --> 240
- | New P4 trial: Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections (clinicaltrials.gov) - Jan 28, 2013
P4, N=100, Not yet recruiting, Sponsor: Chinese University of Hong Kong
- Enrollment open: Testing the AVI-7100 Flu Drug in Healthy Volunteers (clinicaltrials.gov) - Jan 28, 2013
P1, N=150, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=720 --> 240 Not yet recruiting --> Recruiting
- Agriflu (trivalent influenza virus vaccine) / CSL Behring, FLUAD (trivalent inactivated influenza vaccine) / CSL Behring
Enrollment closed, IO biomarker: ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses (clinicaltrials.gov) - Jan 27, 2013
P2, N=90, Active, not recruiting, Sponsor: University of Oxford
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting
- favipiravir / Generic mfg.
Enrollment change: T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza (clinicaltrials.gov) - Jan 24, 2013
P1/2, N=550, Completed, Sponsor: FujiFilm Pharmaceuticals U.S.A., Inc.
Not yet recruiting --> Active, not recruiting N=450 --> 550